Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

3 Utility Stocks to Buy for Safety and Yield in 2024

By Josh Enomoto, InvestorPlace Contributor

While Wall Street celebrated the fact that we avoided a recession in 2023, that doesn’t necessarily mean fortune will favor us again this year, thus…

7 Gold Stocks to Buy for Uncertain Economic Times

By Josh Enomoto, InvestorPlace Contributor

Inherently, the idea of gold stocks generates controversy in some circles because of its relevance – or lack thereof. Often labeled as a “barbarous relic,”…

7 eVTOL Stocks to Invest In the Full Range of Air Mobility

By Josh Enomoto, InvestorPlace Contributor

While everyday mobility generally occurs on the terrestrial realm, the vertical axis opens up several possibilities, thereby bolstering the basic case of eVTOL stocks. With…

Why Is Processa Therapeutics (PCSA) Stock Up 90% Today?

By Josh Enomoto, InvestorPlace Contributor

Processa Pharmaceuticals successfully completed its safety trial for a key cancer drug. Now, PCSA stock is soaring on the positive implications.

Microsoft Layoffs 2024: What to Know About the Latest MSFT Job Cuts

By Josh Enomoto, InvestorPlace Contributor

Although the Microsoft layoffs weren’t unexpected given the size of the Activision Blizzard buyout, it raises questions about MSFT stock.

Load More